Journal
Annals of Clinical and Translational Neurology
Publication Date
2-1-2023
Volume
10
Issue
2
First Page
181
Last Page
194
Document Type
Open Access Publication
DOI
10.1002/acn3.51709
Rights and Permissions
Findlay, A.R., Robinson, S.E., Poelker, S., Seiffert, M., Bengoechea, R. and Weihl, C.C. (2023), LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials. Ann Clin Transl Neurol, 10: 181-194. https://doi.org/10.1002/acn3.51709 © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Recommended Citation
Findlay, Andrew R; Robinson, Sarah E; Poelker, Stephanie; Seiffert, Michelle; Bengoechea, Rocio; and Weihl, Conrad C, "LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials." Annals of Clinical and Translational Neurology. 10, 2. 181 - 194. (2023).
https://digitalcommons.wustl.edu/oa_4/2542
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
